<!DOCTYPE html>
<html lang="en">
	<head>
		<meta charset="utf-8">
		<title>RSS-o-Matic</title>
		<meta name="viewport" content="width=device-width, initial-scale=1.0">
		<meta name="description" content="">
		<meta name="author" content="">

		<!-- Le styles -->
		<link href="css/bootstrap.css" rel="stylesheet">
		<link href="css/bootstrap-responsive.css" rel="stylesheet">
		<link href="css/rss-o-matic.css" rel="stylesheet">

		<!-- HTML5 shim, for IE6-8 support of HTML5 elements -->
		<!--[if lt IE 9]>
			<script src="js/html5shiv.js"></script>
			<![endif]-->

		<!-- Fav and touch icons -->
        <link rel="shortcut icon" href="ico/favicon.png">
	</head>
	<body>
		<div class="main-container">
			<div class="rss-title-container">
				<p class="rss-title-text">
					<img src="img/wl.png" style="height: 48px;" />
					Reuters: Health News
					<img src="img/wl.png" style="height: 48px;" />
				</p>
			</div>

			<div class="rss-items-container" id="i-cont">
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Merck drug to reverse anesthesia delayed again at FDA
					</div>
					
					<div class="rss-item-description-container">
						WASHINGTON (Reuters) - U.S. health regulators need more time to review Merck & Co's application to sell sugammadex, an injection designed to reverse the effects of muscle relaxants used during surgery, the company said on Tuesday.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Lundbeck, Otsuka Alzheimer's drug shows improved cognition in study
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - An experimental drug to treat Alzheimer's disease proved effective in improving cognitive performance in a mid-stage study, Danish pharmaceutical group Lundbeck, one of the drug's two developer's, said on Tuesday.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Digital health records may save some money: study
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters Health) - Switching to electronic health records may lead to a small reduction in spending per patient at doctors' offices, according to a new study.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Prostate cancer hormonal therapy tied to kidney risks
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters Health) - Men who are treated for prostate cancer with hormone-targeted therapy have a higher risk of developing kidney problems, a new study suggests.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Mylan says court dismisses some of Teva's patent claims on MS drug
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - A federal court in New York ruled that Mylan Inc's generic application for a multiple sclerosis drug has not infringed some of Teva Pharmaceutical Industries' patents, Mylan said.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Clamping umbilical cord later may boost babies' iron
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters Health) - Pinching off the umbilical cord as soon as possible after birth may not be best for babies, according to a new review.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Post-op phone checkups save time and travel
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters Health) - In a preliminary study of patients who had simple surgeries, most did well and seemed satisfied with post-operative checkups by telephone instead of seeing their surgeon in a clinic visit.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						U.S. FDA cancels advisory committee on Merck's drug sugammadex
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - The U.S. Food and Drug Administration canceled an advisory committee meeting set for Thursday to discuss Merck & Co's sugammadex, a drug designed to reverse the effects of muscle-relaxants used during surgery.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						FDA grants emergency approval for test to detect MERS
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - The Food and Drug Administration issued an emergency authorization on Tuesday for a diagnostic test to detect the presence of the Middle East coronavirus at the request of the Centers for Disease Control and Prevention.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Later retirement linked to lower risk of Alzheimer's, study shows
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - Workers who postpone retirement are less likely to develop Alzheimer's disease and other forms of dementia known to affect the elderly than those who leave their jobs at age 60, a recent survey of nearly half a million European retirees shows.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Largest cancer gene database made public
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - National Cancer Institute scientists have released the largest-ever database of cancer-related genetic variations, providing researchers the most comprehensive way so far to figure out how to target treatments for the disease.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						HMA urges shareholders to reject Glenview's plan to remove board
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - Hospital operator Health Management Associates Inc is urging its shareholders to reject shareholder Glenview Capital Management's attempt to replace all of its board members with the hedge fund's nominees, according to a federal regulatory filing on Monday.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						It's all about the roll when choosing running shoes
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters) - Fitness experts have long advised clients choosing a running shoe to forget fashion and consider the roll or pronation - the way the foot leans inward upon impact.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Long term aspirin use tied to lower colon cancer risk
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters Health) - Low-dose aspirin, even if not taken daily, may reduce a woman's risk of colon cancer over the long term, according to a new study that did not find the same effect for other types of cancer.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Scientists find how 'obesity gene' makes people fat
					</div>
					
					<div class="rss-item-description-container">
						LONDON (Reuters) - Scientists have unraveled how a gene long associated with obesity makes people fat by triggering increased hunger, opening up potential new ways to fight a growing global health problem.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Past colon cancer tied to future cancer risks
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters Health) - People who have had colon cancer are 15 percent more likely to be diagnosed with another cancer than those with no history of the disease, a new study suggests.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Pregnancy possible for many after childhood cancer
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters Health) - Despite research indicating that women who had cancer as girls have difficulty getting pregnant, a new study suggests that most can conceive, though it might take longer than usual.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Abbott to buy cataract laser, leg stent businesses
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - Abbott Inc said on Monday that it would enter the laser cataract surgery business by buying privately held OptiMedica Corp for up to $400 million and in a separate deal would pay $310 million for stent maker Idev Technologies.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Family planning, higher education are priorities globally: Nielsen poll
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters) - Family planning, higher education and quality time with loved ones are priorities for people around the world, according to a new global Nielsen survey focusing on lifestyle values released on Friday.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Exalenz launches new breath test to detect H. pylori bacteria
					</div>
					
					<div class="rss-item-description-container">
						TEL AVIV (Reuters) - Exalenz Bioscience, a developer of diagnostic systems that use a patient's breath to detect gastrointestinal and liver conditions, launched BreathID Hp, a next generation device in the company's BreathID product line.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						GSK stops using travel agencies accused in Chinese probe
					</div>
					
					<div class="rss-item-description-container">
						LONDON (Reuters) - British drugmaker GlaxoSmithKline said on Monday it had stopped using all travel agencies which have been accused by the Chinese police of channeling bribes to illegally boost sales and inflate the price of its medicines in the country.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						AstraZeneca finance chief Lowth to quit for BG Group
					</div>
					
					<div class="rss-item-description-container">
						LONDON (Reuters) - Simon Lowth is to quit as chief financial officer at AstraZeneca and return to his energy roots in the same role at BG Group after being passed over for the top job at the drugmaker.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Vivus says victim of false statements, delays shareholder meet
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - U.S. drugmaker Vivus Inc, locked in a proxy battle with top investor First Manhattan Co, said FMC's advisers had made false statements to its shareholders and that it would delay its annual meeting by three days to allow FMC to make corrections.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Slapping, shoving tied to kids' future health problems
					</div>
					
					<div class="rss-item-description-container">
						NEW YORK (Reuters Health) - Children who are punished through pushing, shoving and slapping are more likely to be obese and have other health problems when they grow up, a new study suggests.
					</div>
				</div>
				
				<div class="rss-item-container">
					<div class="rss-item-title-container">
						Vivus invites three First Manhattan nominees to join board
					</div>
					
					<div class="rss-item-description-container">
						(Reuters) - Vivus Inc said it has invited three of the nominees proposed by its top investor First Manhattan Co (FMC) to join its board, regardless of the outcome of the vote at the obesity drug maker's annual meeting.
					</div>
				</div>
				
			</div>
		</div>
		<!-- Le javascript
			 ================================================== -->
		<!-- Placed at the end of the document so the pages load faster -->
		<script src="js/bootstrap.js"></script>
		<script src="js/jquery.js"></script>
		<script src="js/rss-o-matic.js"></script>
	</body>
</html>
